Kihara A, Pastan I
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Bioconjug Chem. 1994 Nov-Dec;5(6):532-8. doi: 10.1021/bc00030a008.
Chimeric toxins composed of transforming growth factor alpha fused to mutant forms of Pseudomonas exotoxin bind to the EGF receptor and kill cells bearing these receptors. In early experiments, the binding domain of Pseudomonas exotoxin was deleted and replaced with TGF alpha to make TGF alpha-PE40. This chimeric toxin required proteolytic processing within the target cell to be converted to its active form (Siegall et al. (1989) FASEB J. 3, 2647-2652). Subsequently, recombinant toxins that do not require proteolytic processing were constructed by inserting TGF alpha near the carboxyl terminus of domain III and deleting toxin residues up to the processing site at position 280. In addition, the carboxyl terminus of this toxin was converted from REDLK to KDEL to increase its activity. Recombinant toxins of this type, termed PE37/TGF alpha/KDEL, are about 100-fold more potent than TGF alpha-PE40. To determine if other sequences can be removed from such chimeric toxins to make a smaller molecule that can penetrate tissues better, we have carried out a deletion analysis of sequences present within domains II and Ib. We find that all of domain Ib and a portion of domain II can be deleted without significant loss of cytotoxic activity, but larger deletions extending further into domain II lose cytotoxic activity. We also find that inserting a small linking peptide (Gly)4Ser between residual sequences in domain II and domain III, in molecules with diminished cytotoxic activity, enhances cytotoxicity suggesting that one role of domain Ib is to prevent undesirable interactions between domains II and III.(ABSTRACT TRUNCATED AT 250 WORDS)
由转化生长因子α与铜绿假单胞菌外毒素突变体形式融合而成的嵌合毒素可与表皮生长因子受体结合,并杀死表达这些受体的细胞。在早期实验中,铜绿假单胞菌外毒素的结合结构域被删除,并用转化生长因子α取代,制成了转化生长因子α-PE40。这种嵌合毒素需要在靶细胞内进行蛋白水解加工才能转化为其活性形式(西格尔等人,(1989年)《美国实验生物学会联合会杂志》3,2647 - 2652)。随后,通过在结构域III的羧基末端附近插入转化生长因子α并删除直至第280位加工位点的毒素残基,构建了不需要蛋白水解加工的重组毒素。此外,该毒素的羧基末端从REDLK转化为KDEL以提高其活性。这种类型的重组毒素,称为PE37/转化生长因子α/KDEL,其效力比转化生长因子α-PE40高约100倍。为了确定是否可以从这种嵌合毒素中去除其他序列以制成能更好穿透组织的更小的分子,我们对结构域II和Ib内的序列进行了缺失分析。我们发现结构域Ib的全部和结构域II的一部分可以被删除而不会显著丧失细胞毒性活性,但延伸到结构域II更深处的较大缺失会导致细胞毒性活性丧失。我们还发现,在细胞毒性活性降低的分子中,在结构域II和结构域III的残留序列之间插入一个小的连接肽(甘氨酸)4丝氨酸,可增强细胞毒性,这表明结构域Ib的一个作用是防止结构域II和III之间发生不良相互作用。(摘要截短于250字)